Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank50
3Y CAGR+44.2%
5Y CAGR+13.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+44.2%/yr
vs -14.8%/yr prior
5Y CAGR
+13.4%/yr
Recent acceleration
Acceleration
+58.9pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.15 | +91.3% |
| 2024 | 0.08 | +118.3% |
| 2023 | 0.04 | -28.2% |
| 2022 | 0.05 | -31.2% |
| 2021 | 0.07 | -9.2% |
| 2020 | 0.08 | -0.3% |
| 2019 | 0.08 | -15.3% |
| 2018 | 0.09 | -45.1% |
| 2017 | 0.17 | -41.1% |
| 2016 | 0.29 | - |